Publications and Posters

Targeting ferroptosis with the lipoxygenase inhibitor PTC-041 as a therapeutic strategy for the treatment of Parkinson’s disease
September 18, 2024  •  Minnella, A., McCusker, K. P., Amagata, A., Trias, B., Weetall, M., Latham, J. C., O’Neill, S., Wyse, R. K., Klein, M. B., & Trimmer, J. K. (2024). In H. Nakano (Ed.), PLOS ONE (Vol. 19, Issue 9, p. e0309893). Public Library of Science (PLoS). • Drug study incorporating MALDI-IHC, Pharma
Utilizing multimodal mass spectrometry imaging for profiling immune cell composition and N-glycosylation across colorectal carcinoma disease progression
January 10, 2024  •  Young, L. E. A., Nietert, P. J., Stubler, R., Kittrell, C. G., Grimsley, G., Lewin, D. N., Mehta, A. S., Hajar, C., Wang, K., O’Quinn, E. C., Angel, P. M., Wallace, K., & Drake, R. R. (2024). In Frontiers in Pharmacology (Vol. 14). Frontiers Media SA. • Multiomic, Multimodal